Studying prognostic factors of breast cancer is a traditional subject.

Such inhibitors, in combination with other therapies, may improve the prognosis in breast cancers fueled by these cells.

Conclusions the prognosis of bilateral primary mammary cancer is decided by whether axilla lymph node has transferred, whether the tumor is big or small, and whether the er receptor is positive.